Skip to content
mda-logo_stacked-all white
  • Subscribe
  • Newsletter
  • Advertise
  • MDA.org
  • Donate
Ques_media_logo

Ques_media_logo
Subscribe
Donate

  • Magazine
    • Current Issue
    • Past Issues
  • Featured Content
  • Topics
    • Advocacy
    • Finding a Diagnosis
    • Get Involved
    • Health
    • Inclusion
    • Independence
    • Lifestyle
    • News
    • Personal Stories
    • Science + Research
  • Diseases A-Z
  • Blog
  • Podcast
  • Product Guide
  • Career Quest

Clinical Trials

Creatine kinase (CK), also known as creatine phosphokinase (CPK) or phosphocreatine kinase, is an enzyme expressed by various tissues and cell types. CK catalyses the conversion of creatine and uses adenosine triphosphate (ATP) to create phosphocreatine (PCr) and adenosine diphosphate (ADP). This CK enzyme reaction is reversible and thus ATP can be generated from PCr and ADP.
Blog Post

Simply Stated: RNA-Based Therapies in Development for Myotonic Dystrophy

By Sujatha Gurunathan | January 30, 2025
Titled book Amyotrophic Lateral Sclerosis along with medical equipment, Title of book invented and fictitious made in Photoshop, conceptual image
Blog Post

Simply Stated: Updates in Amyotrophic Lateral Sclerosis (ALS)

By Sujatha Gurunathan | October 29, 2024
Genetic engineeering concept with 3d rendering dna helix and a part of dna
Blog Post

Next-Generation Exon-Skipping Therapies May Change the DMD Landscape

By Myrna Traylor | September 13, 2024
A father, mother, and three sons sit on an outdoor patio step
Blog Post

My Gene Therapy Journey: The Curran Family

By Rebecca Hume | September 5, 2024
Parents hold their four-year-old daughter, who received Zolgensma for spinal muscular atrophy as an infant.
Blog Post

A Revolutionary Decade for Spinal Muscular Atrophy Therapies

By Chris Anselmo | August 1, 2024
Blog Post

Clinical Trial Alert: Phase 2 Pivotal Study of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy

By Sujatha Gurunathan | June 17, 2024
Blog Post

MDA Ambassador Guest Blog: Finding Hope and Optimism in New Treatments

By Chase Rankin | June 4, 2024
Woman in electric wheelchair waits for consultation with doctor in clinic waiting area. Nurse invites patient with disability on procedures. Medical staff and people in modern medical facility lobby.
Blog Post

Treatment Options for Autoimmune Neuromuscular Diseases

By Patrick Sullivan | May 17, 2024
Illustration of digital health technologies
Featured Article

Can Wearables and Smartphones Make Clinical Trials Better?

By Andrew Zaleski | May 9, 2024
Ribonucleic acid strands consisting of nucleotides important for protein bio-synthesis - 3d illustration
Blog Post

Simply Stated: Updates in SELENON-Related Myopathy

By Sujatha Gurunathan | May 7, 2024
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 19
  • Next »
  • Media
  • Careers
  • Donate
  • Contact Quest
muscular-dystrophy-association
Muscular Dystrophy Association, Inc.
1016 W Jackson Blvd #1073
Chicago, IL 60607
800-572-1717 | ResourceCenter@mdausa.org

 

Manage Your Quest Media Subscriptions










The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. ©2022, Muscular Dystrophy Association Inc. All rights reserved.

Privacy Policy | Terms of Use | State Fundraising Notices

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset